The Ross operation in young patients: 15-year's experience from a single Institution - 14/08/21
, Xavier Iriart, MD, W. Albadi, MD, Jean-Benoît Thambo, MD, PhD, François Roubertie, MD, PhD
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Résumé |
Background |
Data on the long-term outcomes in young patients after the Ross operation are limited and the question of the best pulmonary valve substitute remain elusive.
Objective |
This study aimed to assess the long-term outcomes in young patients who underwent the Ross operation with various pulmonary valve substitutes at a single institution.
Methods |
The retrospective study reviewed all patients (n=112) who underwent the Ross operation at the University Hospital of Bordeaux, France between 2004 and 2020.
Results |
Mean follow-up time was 4.2 years. Median age at operation was 15 years. Operative mortality was 0%. There were 1 late death (0,8%). Overall survival at 10 years was 99.2%. Freedom from the right ventricular outflow tract (RVOT) reoperation as better by the homograft compared to xenograft: 5.3 to 20% at 5 years and 5.3 and 65.7% at 10 years.
Conclusion |
The Ross procedure performed in young patients was associated with significative better freedom from RVOT reoperation with homograft compared with xenograft substitutes (P=0,003).
Le texte complet de cet article est disponible en PDF.Plan
Vol 13 - N° 4
P. 296 - septembre 2021 Retour au numéro
Article précédent
- Percutaneous pulmonary valve implantation: Long term outcomes
- Ali Houeijeh, Clément Batteux, Emre Belli, Clément Karsenty, Jérôme Petit, Sébastien Hascoet
- Long-term follow-up of giant coronary aneurysms of Kawasaki disease in a non-Japanese cohort
- Fanny Bajolle, Léa Bergez, Sophie-Guiti Malekzadeh-Milani, Damien Bonnet
Bienvenue sur EM-consulte, la référence des professionnels de santé.